During the past decade, Stephenson Cancer Center conducted 186 clinical trials. In the 10-year time frame, 186 clinical trials started and 106 clinical trials were completed, i.e. on average, 57% percent of trials that started reached the finish line to date. In the past 5 years, 98 clinical trials started and 48 clinical trials were completed. i.e. 49% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stephenson Cancer Center" #1 sponsor was "University of Oklahoma" with 27 trials, followed by "Children's Oncology Group" with 26 trials sponsored, "Radiation Therapy Oncology Group" with 19 trials sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored and "Gynecologic Oncology Group" with 18 trials sponsored. Other sponsors include 193 different institutions and companies that sponsored additional 124 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stephenson Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 93 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Merck Sharp & Dohme LLC" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 7 trials as a collaborator and "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 7 trials as a collaborator. Other collaborators include 121 different institutions and companies that were collaborators in the rest 88 trials.

According to Clinical.Site data, the most researched conditions in "Stephenson Cancer Center" are "Ovarian Cancer" (28 trials), "Breast Cancer" (21 trials), "Endometrial Cancer" (19 trials), "Fallopian Tube Cancer" (17 trials) and "Prostate Cancer" (16 trials). Many other conditions were trialed in "Stephenson Cancer Center" in a lesser frequency.

Most popular intervention types in "Stephenson Cancer Center" are "Drug" (252 trials), "Biological" (45 trials), "Radiation" (44 trials), "Procedure" (37 trials) and "Other" (30 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "radiation therapy" (19 trials), "Paclitaxel" (18 trials), "Carboplatin" (15 trials) and "cyclophosphamide" (13 trials). Other intervention names were less common.

The vast majority of trials in "Stephenson Cancer Center" are 218 trials for "All" genders, 68 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "Stephenson Cancer Center". 1 are not yet recruiting, 68 are recruiting, 61 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 126 completed trials in Stephenson Cancer Center, 1 suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in Stephenson Cancer Center, 113 "Phase 1" clinical trials were conducted, 126 "Phase 2" clinical trials and 80 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 16 trials that are defined as “Not Applicable".